CW August 2002
Volume 11Issue Number 8 August 2002 ISSN 10593802 New Anti-emetic Aids Standard TherapyAdding a neurokinin 1 receptor antagonist (NK1 RA) to standard anti-emetic therapy for cancer patients sustains protection against nausea and vomiting over multiple chemotherapy cycles.
Go to Previous Page Go to Next Page Source & Additional Reading ASCO Annual Meeting, Orlando. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW August 2002Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
